O65 HIGH RATE OF SUSTAINED VIROLOGIC RESPONSE IN PATIENTS WITH HCV GENOTYPE-1A INFECTION: A PHASE 2 TRIAL OF FALDAPREVIR, DELEOBUVIR AND PPI-668, WITH AND WITHOUT RIBAVIRIN

Jacob Lalezari, L. J. Holland, E. Glutzer, Pamela Vig, M. Elgadi, Jerry O. Stern, Richard J. Colonno, Siman-Tov Halfon, Eric Ruby, Nanqi Huang, E.F. Nash, Nathaniel Brown

Journal of Hepatology

April 1, 2014

10.1016/s0168-8278(14)60067-2

Cited by 4

Abstract

Related Papers

No related papers found

Powered by citation graph analysis